Ashton Thomas Private Wealth, LLC Gilead Sciences, Inc. Transaction History

Ashton Thomas Private Wealth, LLC

  • $1.9 Trillion
  • Q3 2024

A detailed history of Ashton Thomas Private Wealth, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 43,285 shares of GILD stock, worth $4.09 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
43,285
Previous 44,450 2.62%
Holding current value
$4.09 Million
Previous $3.05 Billion 19.0%
% of portfolio
0.19%
Previous 0.17%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$66.59 - $83.99 $77,577 - $97,848
-1,165 Reduced 2.62%
43,285 $3.63 Billion
Q2 2024

Aug 06, 2024
BUY
$63.15 - $72.88 $51,656 - $59,615
818 Added 1.87%
44,450 $3.05 Billion
Q1 2024

Apr 19, 2024
SELL
$71.58 - $87.29 $44,594 - $54,381
-623 Reduced 1.41%
43,632 $3.2 Billion
Q4 2023

Apr 19, 2024
BUY
$73.27 - $83.09 $5,495 - $6,231
75 Added 0.17%
44,255 $3.59 Billion
Q3 2023

Apr 19, 2024
SELL
$73.94 - $80.67 $2.23 Million - $2.44 Million
-30,202 Reduced 40.6%
44,180 $3.31 Billion
Q2 2023

Apr 22, 2024
BUY
$76.01 - $86.7 $122,908 - $140,193
1,617 Added 3.93%
42,772 $3.3 Billion
Q1 2023

Apr 22, 2024
SELL
$77.31 - $88.08 $191,496 - $218,174
-2,477 Reduced 5.68%
41,155 $3.41 Billion
Q4 2022

Apr 19, 2024
BUY
$62.32 - $89.47 $62,943 - $90,364
1,010 Added 1.38%
74,382 $6.39 Billion
Q3 2022

Apr 19, 2024
BUY
$59.54 - $68.01 $726,447 - $829,790
12,201 Added 19.95%
73,372 $4.53 Billion
Q2 2022

Apr 19, 2024
BUY
$57.72 - $65.01 $716,882 - $807,424
12,420 Added 25.48%
61,171 $3.78 Billion
Q1 2022

Apr 19, 2024
BUY
$57.92 - $72.58 $470,542 - $589,639
8,124 Added 20.0%
48,751 $2.9 Billion
Q4 2021

Apr 19, 2024
BUY
$64.88 - $73.64 $1.44 Million - $1.63 Million
22,157 Added 119.96%
40,627 $2.95 Billion
Q3 2021

Apr 19, 2024
BUY
$67.69 - $73.03 $25,383 - $27,386
375 Added 2.07%
18,470 $1.29 Billion
Q2 2021

Apr 19, 2024
BUY
$63.47 - $69.35 $485,355 - $530,319
7,647 Added 73.19%
18,095 $1.25 Billion
Q1 2021

Apr 19, 2024
BUY
$60.0 - $68.46 $626,880 - $715,270
10,448 New
10,448 $675 Million

Others Institutions Holding GILD

# of Institutions
1,926
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Ashton Thomas Private Wealth, LLC Portfolio

Follow Ashton Thomas Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email